Platforms

Genomic and Molecular Services

Next generation sequencing

Next Generation Sequencing platforms allow MOgene to choose a relevant technology best suited for each project. We start with your testing goals in mind, then offer flexible, adaptable, and developmental options tailored to your specific needs.

Illumina Short Read Platform

MOgene offers cutting edge technology for Next Generation Sequencing (NGS) across multiple Illumina instruments, allowing us to match the scope of your projects and return results quickly.

Whole genome and exome sequencing
de novo sequencing
Targeted sequencing
Amplicon sequencing
Small RNA sequencing
16S metagenomics
RNA-Seq

PacBio SMRT Long Read Platform

MOgene offers all sequencing services on the PacBio Sequel sequencing system. The Sequel system is a next generation of SMRT (Single-Molecule, Real-Time) sequencing that is designed to solve problems in genome, transcriptome, and epigenetics research.

Some of the typical applications are –

Whole Genome and exome sequencing
de novo sequencing
Targeted sequencing
Amplicon/COSMID sequencing
IsoSeq (Isoform detection)
Metagenomics

GET IN TOUCH

i

Quote Request



Contact Us

agilent microarrays and NanoString Profiler

From whole genome expression studies, to low density arrays, or qPCR analysis of a small subset of genes, MOGene offers the complete range of Agilent microarrays. We work with clients to design the most effective transcript profiling experiments, selecting arrays best suited to their research goals, assist with determining the number and types of replicates to use, and selecting the most powerful data analysis method.

Agilent Microarrays

As a Certified Agilent Service Provider we provide a complete solution for your microarray needs, including high-throughput array processing for any type of project.

MicroRNA Expression
Gene Expression
Genotyping
Methylation
ChiP on ChiP
aCGH

NanoString nCounter® SPRINT Profiler

MOgene has been a premiere clinical and non-clinical genomic services provider for more than 15 years. Our team has years of experience and can offer services for all NanoString technologies. The nCounter® platform provides a simple and cost effective solution for multiplex analyses of up to 800 RNA, DNA, or protein targets from your samples.

Gene Expression (mRNA as well as microRNA)
Protein abundance
SNP genotyping
CNV analysis

real-time pcr and droplet digital™ pcr

Real-time PCR remains one of the most sensitive and quantitative tools for gene expression. MOgene offers both customized and pre-optimized qPCR assays for a wide variety of applications for gene expression, genetic variation, and epigenetic analysis in regulated projects. We manage all aspects of the project from assay design, nucleic acid isolation and data analysis.

QuantStudio™ 12k Flex OpenArray System

Utilizing the ABI QuantStudio™ 12k Flex OpenArray system MOgene has the capability of running hundreds of real-time PCR reactions simultaneously. This flexible system allows us to provide you with a collection of different configurations to match your requirements.

Viral load determination
Gene expression
SNP genotyping
miRNA analysis
CNV analysis

Droplet Digital™ PCR (ddPCR™)

The BIO-RAD ddPCR™ system provides high-precision, absolute quantitation of nucleic acids in a wide variety of applications in both research and clinical diagnostics.

Detection of rare mutations and sequences
Genome edit detection
Single cell analysis
Viral load determination
Gene expression
SNP genotyping
miRNA analysis
CNV analysis

Quality and safety

The Quality Commitment From MOgene

Regulatory Services

MOgene has an established reputation of complying with relevant national and international quality compliance regulations.

Audit ready for clients with routine internal quality audits
GLP compliance per FDA 21 CFR Part 58 and Part 11
Active CAPA program for process improvement
CLIA Certification
USDA Certification

Quality Management System

MOgene has a robust Quality Management System (QMS) detailed in a manual that ensures compliance for quality monitoring and improvement.

Transparent and routine communications on project timelines and deliverables
Complete documentation of standard operating procedures (SOPs) and 100% QC of data
Rigorous sample management process

BioSafety

Our Biosafety practices enable us to provide services for early R&D and market release studies for pathogens that require BSL-2+ facilities.

Higher levels of lab safety for antimicrobial, human and animal health vaccine development
Dedicated BSL-2+ Lab and pre-amplification room for your clinical studies
Trained personnel to handle BSL-2+ level agents
UNIDIRECTIONAL workflow